| GO | Name | 
	
		| GO:0000122  | negative regulation of transcription by RNA polymerase II | 
	
		| GO:0000785  | chromatin | 
	
		| GO:0000976  | transcription cis-regulatory region binding | 
	
		| GO:0000978  | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 
	
		| GO:0000981  | DNA-binding transcription factor activity, RNA polymerase II-specific | 
	
		| GO:0000987  | cis-regulatory region sequence-specific DNA binding | 
	
		| GO:0001227  | DNA-binding transcription repressor activity, RNA polymerase II-specific | 
	
		| GO:0001228  | DNA-binding transcription activator activity, RNA polymerase II-specific | 
	
		| GO:0001701  | in utero embryonic development | 
	
		| GO:0001709  | cell fate determination | 
	
		| GO:0001764  | neuron migration | 
	
		| GO:0001806  | type IV hypersensitivity | 
	
		| GO:0001817  | regulation of cytokine production | 
	
		| GO:0001822  | kidney development | 
	
		| GO:0001823  | mesonephros development | 
	
		| GO:0002088  | lens development in camera-type eye | 
	
		| GO:0002520  | immune system development | 
	
		| GO:0002572  | pro-T cell differentiation | 
	
		| GO:0003180  | aortic valve morphogenesis | 
	
		| GO:0003215  | cardiac right ventricle morphogenesis | 
	
		| GO:0003281  | ventricular septum development | 
	
		| GO:0003677  | DNA binding | 
	
		| GO:0003700  | DNA-binding transcription factor activity | 
	
		| GO:0005134  | interleukin-2 receptor binding | 
	
		| GO:0005634  | nucleus | 
	
		| GO:0005654  | nucleoplasm | 
	
		| GO:0006338  | chromatin remodeling | 
	
		| GO:0006357  | regulation of transcription by RNA polymerase II | 
	
		| GO:0006952  | defense response | 
	
		| GO:0006959  | humoral immune response | 
	
		| GO:0007165  | signal transduction | 
	
		| GO:0007411  | axon guidance | 
	
		| GO:0007596  | blood coagulation | 
	
		| GO:0008134  | transcription factor binding | 
	
		| GO:0008270  | zinc ion binding | 
	
		| GO:0008285  | negative regulation of cell population proliferation | 
	
		| GO:0008584  | male gonad development | 
	
		| GO:0009615  | response to virus | 
	
		| GO:0009653  | anatomical structure morphogenesis | 
	
		| GO:0009791  | post-embryonic development | 
	
		| GO:0009967  | positive regulation of signal transduction | 
	
		| GO:0010332  | response to gamma radiation | 
	
		| GO:0010595  | positive regulation of endothelial cell migration | 
	
		| GO:0010719  | negative regulation of epithelial to mesenchymal transition | 
	
		| GO:0010975  | regulation of neuron projection development | 
	
		| GO:0014065  | phosphatidylinositol 3-kinase signaling | 
	
		| GO:0016579  | protein deubiquitination | 
	
		| GO:0019221  | cytokine-mediated signaling pathway | 
	
		| GO:0030217  | T cell differentiation | 
	
		| GO:0030218  | erythrocyte differentiation | 
	
		| GO:0030856  | regulation of epithelial cell differentiation | 
	
		| GO:0031929  | TOR signaling | 
	
		| GO:0032689  | negative regulation of interferon-gamma production | 
	
		| GO:0032703  | negative regulation of interleukin-2 production | 
	
		| GO:0032736  | positive regulation of interleukin-13 production | 
	
		| GO:0032753  | positive regulation of interleukin-4 production | 
	
		| GO:0032754  | positive regulation of interleukin-5 production | 
	
		| GO:0033600  | negative regulation of mammary gland epithelial cell proliferation | 
	
		| GO:0035162  | embryonic hemopoiesis | 
	
		| GO:0035457  | cellular response to interferon-alpha | 
	
		| GO:0035799  | ureter maturation | 
	
		| GO:0035898  | parathyroid hormone secretion | 
	
		| GO:0042421  | norepinephrine biosynthetic process | 
	
		| GO:0042472  | inner ear morphogenesis | 
	
		| GO:0042493  | response to drug | 
	
		| GO:0042802  | identical protein binding | 
	
		| GO:0043370  | regulation of CD4-positive, alpha-beta T cell differentiation | 
	
		| GO:0043523  | regulation of neuron apoptotic process | 
	
		| GO:0043583  | ear development | 
	
		| GO:0043627  | response to estrogen | 
	
		| GO:0045061  | thymic T cell selection | 
	
		| GO:0045064  | T-helper 2 cell differentiation | 
	
		| GO:0045087  | innate immune response | 
	
		| GO:0045165  | cell fate commitment | 
	
		| GO:0045471  | response to ethanol | 
	
		| GO:0045582  | positive regulation of T cell differentiation | 
	
		| GO:0045599  | negative regulation of fat cell differentiation | 
	
		| GO:0045786  | negative regulation of cell cycle | 
	
		| GO:0045892  | negative regulation of transcription, DNA-templated | 
	
		| GO:0045893  | positive regulation of transcription, DNA-templated | 
	
		| GO:0045944  | positive regulation of transcription by RNA polymerase II | 
	
		| GO:0048469  | cell maturation | 
	
		| GO:0048485  | sympathetic nervous system development | 
	
		| GO:0048538  | thymus development | 
	
		| GO:0048568  | embryonic organ development | 
	
		| GO:0048589  | developmental growth | 
	
		| GO:0048646  | anatomical structure formation involved in morphogenesis | 
	
		| GO:0050728  | negative regulation of inflammatory response | 
	
		| GO:0050852  | T cell receptor signaling pathway | 
	
		| GO:0051569  | regulation of histone H3-K4 methylation | 
	
		| GO:0051897  | positive regulation of protein kinase B signaling | 
	
		| GO:0060017  | parathyroid gland development | 
	
		| GO:0060037  | pharyngeal system development | 
	
		| GO:0060065  | uterus development | 
	
		| GO:0060231  | mesenchymal to epithelial transition | 
	
		| GO:0060374  | mast cell differentiation | 
	
		| GO:0060676  | ureteric bud formation | 
	
		| GO:0061085  | regulation of histone H3-K27 methylation | 
	
		| GO:0061290  | canonical Wnt signaling pathway involved in metanephric kidney development | 
	
		| GO:0070888  | E-box binding | 
	
		| GO:0071353  | cellular response to interleukin-4 | 
	
		| GO:0071356  | cellular response to tumor necrosis factor | 
	
		| GO:0071442  | positive regulation of histone H3-K14 acetylation | 
	
		| GO:0071599  | otic vesicle development | 
	
		| GO:0071773  | cellular response to BMP stimulus | 
	
		| GO:0071837  | HMG box domain binding | 
	
		| GO:0072107  | positive regulation of ureteric bud formation | 
	
		| GO:0072178  | nephric duct morphogenesis | 
	
		| GO:0072179  | nephric duct formation | 
	
		| GO:0072182  | regulation of nephron tubule epithelial cell differentiation | 
	
		| GO:0072197  | ureter morphogenesis | 
	
		| GO:0072676  | lymphocyte migration | 
	
		| GO:0090102  | cochlea development | 
	
		| GO:1901536  | negative regulation of DNA demethylation | 
	
		| GO:1902036  | regulation of hematopoietic stem cell differentiation | 
	
		| GO:1902895  | positive regulation of pri-miRNA transcription by RNA polymerase II | 
	
		| GO:1990837  | sequence-specific double-stranded DNA binding | 
	
		| GO:2000114  | regulation of establishment of cell polarity | 
	
		| GO:2000146  | negative regulation of cell motility | 
	
		| GO:2000352  | negative regulation of endothelial cell apoptotic process | 
	
		| GO:2000553  | positive regulation of T-helper 2 cell cytokine production | 
	
		| GO:2000607  | negative regulation of cell proliferation involved in mesonephros development | 
	
		| GO:2000611  | positive regulation of thyroid hormone generation | 
	
		| GO:2000617  | positive regulation of histone H3-K9 acetylation | 
	
		| GO:2000679  | positive regulation of transcription regulatory region DNA binding | 
	
		| GO:2000683  | regulation of cellular response to X-ray | 
	
		| GO:2000703  | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation | 
	
		| GO:2000734  | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation |